Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NIH
NIH
NIH abandons trial of SIGA's mpox drug
Pharmaphorum
Thu, 12/12/24 - 11:31 am
SIGA technologies
mpox
NIH
clinical trials
Tecovirimat
Trump chooses US COVID policy critic Bhattacharya to lead NIH
MSN/Reuters
Tue, 11/26/24 - 10:23 pm
NIH
Donald Trump
Jay Bhattacharya
New Alzheimer's prevention trial receives $74.5 million NIH grant
Drugs.com
Sun, 11/17/24 - 09:22 pm
Eli Lilly
Alzheimer's disease
NIH
clinical trials
What RFK Jr.’s influence could mean for pharma
Pharma Voice
Fri, 11/8/24 - 11:45 am
Robert F Kennedy Jr.
Donald Trump
healthcare reform
FDA
CDC
CMS
NIH
Bavarian Nordic’s Mpox Vaccine Safe, Effective at Lower Doses: Study
BioSpace
Mon, 04/29/24 - 10:51 pm
Bavarian Nordic
vaccines
mpox
Jynneos
NIH
BioNTech gets US agency notice over default on COVID vaccine royalties
Reuters
Mon, 03/25/24 - 11:20 am
BioNTech
NIH
COVID-19
vaccines
How a looming government shutdown could affect healthcare
Medical Marketing and Media
Sun, 09/24/23 - 09:09 pm
government shutdown
clinical trials
NIH
NIH begins human trials of 'universal' flu vaccine
Yahoo/Reuters
Sun, 09/17/23 - 09:21 pm
NIH
clinical trials
vaccines
universal flu vaccine
FluMos-v2
US to test Paxlovid as long COVID-19 therapy
Beckers Hospital Review
Wed, 08/2/23 - 10:22 am
clinical trials
Long COVID
Pfizer
Paxlovid
NIH
NIH begins long-delayed clinical trials for long Covid, announces new research office
Stat
Tue, 08/1/23 - 11:52 am
NIH
COVID-19
Long COVID
clinical trials
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Endpoints
Wed, 04/5/23 - 07:15 pm
Amgen
Prolia
Xgeva
denosumab
clinical trials
NIH
biosimilars
monoclonal antibodies
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
Sun, 03/26/23 - 03:44 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Sun, 03/26/23 - 03:36 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi
Fierce Pharma
Wed, 03/22/23 - 11:19 am
Pfizer
Astellas
Xtandi
prostate cancer
drug pricing
NIH
march-in rights
Synaptogenix reports disappointing data from Phase II Alzheimer’s trial
Clinical Trials Arena
Mon, 12/19/22 - 11:08 am
Synaptogenix
clinical trials
NIH
Alzheimer's disease
Bryostatin-1
NIH-Supported Clinical Trial of Phage Therapy for Cystic Fibrosis Begins
Drugs.com
Wed, 10/5/22 - 07:15 pm
phages
clinical trials
NIH
cystic fibrosis
Adaptive Phage Therapeutics
NIH launches the next stage of its ‘human genome project’ for the brain
Stat
Mon, 09/26/22 - 10:44 am
NIH
Human Genome Project
brain cells
FDA, NIH initiative aims to speed development of drugs for ALS, other brain diseases
BioPharma Dive
Mon, 09/19/22 - 09:07 am
ALS
drug development
NIH
FDA
Oligomerix receives NIH grant for Phase Ia Alzheimer’s disease study
Clinical Trials Arena
Wed, 08/10/22 - 10:45 am
Oligomerix
NIH
clinical trials
Alzheimer's disease
OLX-07010
NIH awards $577m to antiviral drug developers
Biopharma Reporter
Tue, 05/24/22 - 10:15 am
NIH
NIAID
antivirals
drug development
pandemic
Pages
1
2
3
4
5
6
next ›
last »